Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide an initial assessment of the safety, tolerability and
efficacy of ISIS 113715 in combination with sulfonylurea in type 2 diabetes subjects.